Nextech Invest

Nextech Invest is a premier global venture capital firm dedicated to identifying and nurturing groundbreaking advances in precision medicine. With a strong focus on oncology therapeutics, Nextech Invest is committed to driving value creation for its portfolio companies by investing in promising drug discovery ventures that have the potential to develop multiple life-changing medicines.

Headquartered in Zurich, Switzerland, at Bahnhofstrasse 18, Floor 4, 8001, CH, and with a significant presence at 3 Executive Park Rd, 304, Newton, Massachusetts 02462, US, Nextech Invest operates across the US and Europe. The firm's investment strategy spans from company inception to crossover rounds, ensuring comprehensive support for its portfolio companies throughout their growth journey.

Since its founding in 1998, Nextech Invest has been at the forefront of venture capital, consistently seeking out and supporting innovative solutions in the fight against cancer. We are confident that further details about Nextech Invest's mission and achievements will be completed soon with the support of the company’s management. We invite the manager of Nextech Invest to create a customized and exclusive company showcase and product listing on our platform.